Association Between Famotidine Use and COVID-19 Severity in Hong Kong: A Territory-wide Study
- 1 April 2021
- journal article
- letter
- Published by Elsevier BV in Gastroenterology
- Vol. 160 (5), 1898-1899
- https://doi.org/10.1053/j.gastro.2020.05.098
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort StudyGastroenterology, 2020
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19New England Journal of Medicine, 2020
- ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysisPharmacological Research, 2020
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methodsActa Pharmaceutica Sinica. B, 2020
- Application of Big Data analysis in gastrointestinal researchWorld Journal of Gastroenterology, 2019
- Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trialsIntensive Care Medicine, 2017